ArticleDiscover oncology2025

Astragaloside IV represses hepatocellular carcinoma progression by modulating HMGB1-ferroptosis axis.

Xingyang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.